I'm why you're here

Christian

Doctors developed a modified treatment program to aggressively treat his cancer

Diagnosis: Medulloblastoma

Hobbies: Cub Scouts, Music

Favorite Song: “Don’t Stop Believing” by the Glee Cast

CHIP Impact:  Collaborative collection of chip data, including Colorado Children’s Hospital, has enabled us to realize that even children with metastatic disease can be cured with the application of modified therapy.

Christian was an active and loving 3-year-old when diagnosed with a malignant brain tumor (Medulloblastoma) on July 15th, 2005. Christian was rushed to Children’s Hospital where his family was met by Dr. Foreman and Dr. Handler.

Within a few days of diagnosis, Christian underwent an eight-hour surgery to remove the tumor at the skilled hands of Dr. Handler. He then stayed in the hospital for 2 ½ weeks to recover. His roller coaster ride continued when cancer cells were found during a spinal tap performed on August 3rd  of that same year.

Christian underwent a six-week high dose radiation and chemotherapy treatment cycle at University of Colorado and Children’s Hospital, which he finished in September of 2005. Christian repeated a chemotherapy cycle every six weeks, the last of which was completed in September 2006.

At this point, Christian’s prognosis is very good thanks to Dr. Foreman and the amazing staff at The Children’s Hospital. Christian has benefited from the research funded by the Morgan Adams Foundation. His last MRI performed was on October of 2011 and showed no signs of cancer.

Christian is looking forward to starting fourth grade this fall. He’s a happy, easy going 10-year-old who loves life. He currently performs with a children’s choir and had the privilege of singing a duet during the winter and spring performances. He also participates in Cub Scouts and has earned his Bear and Wolf badge. He continues to amaze us and we are so proud of him.  

The Morgan Adams Foundation funded the Micro Array Chip that differentiated Christian’s cancer and allowed Dr. Foreman’s team to develop a modified treatment program to aggressively treat it.